Biochemical and biological activity of arginine deiminase from Streptococcus pyogenes M22

Eleonora A Starikova1, Alexey V Sokolov1,2, Anna Yu Vlasenko1

  • 1a Institute of Experimental Medicine, 12 Pavlov Street, St. Petersburg, 197376, Russia.

Insights

Streptococcus pyogenes releases arginine deiminase (AD), an enzyme that suppresses endothelial cell proliferation. This bacterial enzyme shows potential for controlling excessive cell growth by affecting cell cycle progression.

Area of Science:

  • Microbiology
  • Biochemistry
  • Cell Biology

Background:

  • Streptococcus pyogenes (group A Streptococcus; GAS) is a gram-positive bacterium causing suppurative infections.
  • GAS employs complex virulence mechanisms to evade host defenses, including factors that affect host cell functions.
  • Previous studies indicated that GAS type M22 supernatant inhibits endothelial cell functions like proliferation.

Purpose of the Study:

  • To isolate and characterize a component from GAS type M22 supernatant with endothelial cell antiproliferative activity.
  • To investigate the properties and mechanism of action of the identified antiproliferative enzyme.

Main Methods:

  • Isolation and purification of a protein with antiproliferative activity from GAS type M22 supernatant.
  • Enzyme kinetics analysis of arginine deiminase (AD), including determination of Km and Vmax.
  • Assessment of AD's effect on endothelial cell proliferation and cell cycle distribution (G0/G1, S/G2 phases).
  • Evaluation of the effect of L-arginine supplementation on AD-mediated inhibition of cell proliferation.

Main Results:

  • Arginine deiminase (AD) was identified as the component suppressing endothelial cell proliferation.
  • GAS M22 AD exhibits optimal activity near neutral pH (pH 6.8), with Km of 0.67 mmol·L(-1) and Vmax of 42 s(-1).
  • AD inhibited endothelial cell proliferation in a dose-dependent manner, increasing the proportion of cells in G0/G1 phase.
  • L-arginine partially reversed AD's inhibitory effect on proliferation, suggesting arginine depletion as a mechanism.

Conclusions:

  • Arginine deiminase from GAS type M22 is a key enzyme that suppresses endothelial cell proliferation.
  • The enzyme's activity is influenced by pH and substrate availability (L-arginine).
  • GAS M22 AD demonstrates potential for therapeutic applications in controlling excessive cell proliferation.

Related Concept Videos